Recently Published GRAS Notices and FDA Letters

For a full listing of notices and response letters, please visit the inventory database.

GRN No.	Substance	GRAS Notice	FDA Letter
1282	Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni)		FDA has no questions (PDF 257 kB)
1277	Autoclaved Parabacteroides goldsteinii "RV-01"		FDA ceased to evaluate (PDF 293 kB)
1274	2'-Fucosyllactose		FDA has no questions (PDF 353 kB)
1265	Saccharomyces cerevisiae "BY-1532"		FDA has no questions (PDF 270 kB)
1264	Lacticaseibacillus rhamnosus CGMCC18639		FDA has no questions (PDF 268 kB)
1260	Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni)		FDA has no questions (PDF 260 kB)
1259	Fungal oil (≥40% arachidonic acid (ARA)) from Mortierella alpina strain TKA-1		FDA has no questions (PDF 198 kB)
1255	Mycelial biomass of Fusarium compactum CGMCC 41312 (fungal protein)		FDA has no questions (PDF 251 kB)
1252	Saccharomyces cerevisiae "BY-1568"		FDA has no questions (PDF 162 kB)
1251	Saccharomyces cerevisiae expressing a gene encoding a cysteine-thiol lyase from Staphylococcus hominis (S. cerevisiae "OYR-290")		FDA has no questions (PDF 164 kB)
1249	Ovalbumin produced by Trichoderma reesei ATCC 13631		FDA has no questions  (PDF 206 kB)
1248	Yeast biomass produced by Kluyveromyces marxianus CCTCC M 20211265		FDA has no questions  (PDF 236 kB)
1247	β-Lactoglobulin produced by Kluyveromyces lactis CCTCC M20241460		FDA has no questions  (PDF 209 kB)
1246	Saccharomyces cerevisiae BY-1248		FDA has no questions  (PDF 172 kB)
1245	Lactiplantibacillus plantarum DSM 21379		FDA has no questions  (PDF 173 kB)
1244	Lactiplantibacillus plantarum DSM 21380		FDA has no questions  (PDF 174 kB)
1243	Bacillus coagulans M2017813 spore preparation		FDA has no questions  (PDF 205 kB)
1242	Short-chain fructooligosaccharides		FDA has no questions  (PDF 94 kB)
1241	β-Lactoglobulin produced by Aspergillus oryzae		FDA has no questions  (PDF 253 kB)
1240	Lacticaseibacillus rhamnosus ATCC PTA-126815		FDA has no questions  (PDF 92 kB)
1239	Bifidobacterium animalis subsp. lactis PTA-126817		FDA has no questions  (PDF 92 kB)
1238	2′-fucosyllactose		FDA has no questions  (PDF 113 kB)
1237	β-glucanase enzyme preparation produced by Talaromyces versatilis		FDA ceased to evaluate  (PDF 146 kB)
1236	Algal oil (≥40% docosahexaenoic acid) from Aurantiochytrium limacinum H Sc-01		FDA has no questions  (PDF 240 kB)
1235	Bifidobacterium lactis CCTCC M 2014588		FDA has no questions  (PDF 210 kB)
1234	Sansho (Zanthoxylum piperitum) pepper extract		FDA has no questions  (PDF 86 kB)
1233	Sansho (Zanthoxylum piperitum) pepper distillate		FDA has no questions  (PDF 85 kB)
1232	Lacticaseibacillus paracasei subsp. paracasei strain DSM 28047		FDA has no questions (PDF 252 kB)
1231	Bacillus velezensis PTA-127359		FDA has no questions  (PDF 92 kB)
1230	Vanillin preparation produced by Escherichia coli BL21(DE3) SI-VAN1		FDA has no questions  (PDF 101 kB)
1229	Levilactobacillus brevis DPC-6108		FDA has no questions (PDF 149 kB)
1227	Korean red ginseng (Panax ginseng C.A. Meyer) root extract		FDA ceased to evaluate  (PDF 116 kB)
1226	Orange (Citrus sinensis) extract		FDA has no questions  (PDF 156 kB)
1225	Sakura (Prunus speciosa) leaf distillate		FDA has no questions  (PDF 82 kB)
1224	Sakura (Prunus serrulata Lindl.) flower extract		FDA has no questions  (PDF 89 kB)
1223	Sakura (Prunus serrulata Lindl.) flower distillate		FDA has no questions  (PDF 84 kB)
1222	Saccharomyces cerevisiae  OYR-542		FDA has no questions  (PDF 97 kB)
1221	Heyndrickxia coagulans NRRL B-67744		FDA has no questions  (PDF 224 kB)
1220	Mycelial biomass from Pleurotus pulmonarius		FDA ceased to evaluate  (PDF 139 kB)
1219	Recombinant bovine lactoferrin isolate produced by Komagataella phaffii M020 expressing the gene encoding bovine lactoferrin		FDA has no questions  (PDF 179 kB)
1218	Bacillus subtilis NRRL 68054		FDA has no questions  (PDF 215 kB)
1217	Algal oil (≥40% docosahexaenoic acid) from Aurantiochytrium limacinum CCAP A1		FDA ceased to evaluate  (PDF 202 kB)
1216	Galacto-oligosaccharides		FDA ceased to evaluate  (PDF 216 kB)
1215	Bacteriophage (phage) preparation specific to Listeria monocytogenes		FDA has no questions  (PDF 179 kB)
1214	Bacillus clausii UBBC-07 spore preparation		FDA has no questions  (PDF 179 kB)
1213	Goat milk lactose		FDA has no questions  (PDF 244 kB)
1212	Liquid whole goat milk		FDA has no questions  (PDF 244 kB)
1211	Reduced minerals goat whey		FDA has no questions  (PDF 268 kB)
1210	Glucosyltransferase enzyme preparation produced by Bacillus subtilis expressing the gene encoding glucosyltransferase from Streptococcus salivarius		FDA has no questions  (PDF 171 kB)
1209	Algal oil (≥35% docosahexaenoic acid) from Schizochytrium limacinum A2		FDA ceased to evaluate  (PDF 378 kB)
1208	Lacto-N-triose II		FDA has no questions  (PDF 285 kB)
1207	Brazzein preparation produced by Aspergillus oryzae 90402 expressing a gene encoding for brazzein from Pentadiplandra brazzeana		FDA has no questions  (PDF 234 kB) Correction Letter   (PDF 89 kB)
1206	Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni		FDA has no questions  (PDF 253 kB)
1205	Lactiplantibacillus plantarum DR7		FDA has no questions  (PDF 174 kB)
1204	Lacticaseibacillus casei Zhang		FDA has no questions  (PDF 204 kB)
1203	Rebaudioside M2 obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni		FDA has no questions  (PDF 191 kB)
1202	Soy leghemoglobin preparation from a strain of Komagataella phaffii		FDA has no questions  (PDF 246 kB)
1201	Lipase enzyme preparation produced by Komagataella phaffii expressing a gene encoding lipase from Yarrowia lipolytica		FDA has no questions  (PDF 181 kB) Correction Letter  (PDF 193 kB)
1200	β-lactoglobulin produced by Komagataella phaffii strain “VIPLA”		FDA has no questions  (PDF 289 kB)
1199	Rhamnogalacturonan-I		FDA has no questions  (PDF 331 kB)
1198	Inositol		FDA has no questions  (PDF 831 kB)
1197	Fructanase enzyme preparation produced by Trichoderma reesei AR-577 expressing the gene encoding fructanase from Lactobacillus crispatus		FDA has no questions  (PDF 257 kB)
1196	Triacylglycerol lipase enzyme preparation produced by Trichoderma reesei expressing a gene encoding an engineered triacylglycerol lipase from Thermomyces lanuginosus		FDA has no questions  (PDF 185 kB)
1195	Chymosin enzyme preparation produced by Aspergillus niger expressing a gene encoding chymosin from Erinaceus europaeus		FDA has no questions  (PDF 192 kB)
1194	Partially hydrolyzed eggshell membrane powder derived from chicken eggs		FDA ceased to evaluate  (PDF 175 kB)
1193	D-psicose		FDA has no questions  (PDF 831 kB)
1192	Tannase enzyme preparation produced by Aspergillus oryzae		FDA has no questions  (PDF 280 kB)
1191	Ergothioneine produced by Escherichia coli BL-21 (DE3) expressing ergothioneine synthases from Schizosaccharomyces pombe		FDA has no questions  (PDF 326 kB)
1190	Saccharomyces cerevisiae strain OYR-481 expressing a gene encoding acetolactate decarboxylase from Brevibacillus brevis	GRN 1190 with amendments  (PDF, 5.5 MB)	FDA has no questions  (PDF 233 kB)
1189	Dry whole goat milk		FDA has no questions  (PDF 180 kB)
1188	D-psicose		FDA has no questions  (PDF 267 kB)
1187	Polygalacturonase enzyme preparation produced by Trichoderma reesei expressing a gene encoding polygalacturonase from Aspergillus luchuensis mut kawachii		FDA has no questions  (PDF 180 kB)
1186	Fungal oil (≥38% arachidonic acid (ARA)) from Mortierella alpina FJRK-MA01	GRN 1186 (PDF 7.2 MB)	Notice does not provide a basis for a GRAS determination  (PDF 273 kB)
1185	Algal oil (≥35% docosahexaenoic acid from Schizochytrium sp. FJRK-SCH3	GRN 1185 (PDF 8.4 MB)	Notice does not provide a basis for a GRAS determination  (PDF 245 kB)
1184	Rebaudioside M from a modified strain of Escherichia coli BL21(DE3)		FDA has no questions  (PDF 245 kB)
1183	Monellin preparation produced by Komagataella phaffii P-MON-040 expressing a gene encoding for a modified monellin	GRN 1183 with amendments  (PDF, 5.5 MB)	FDA has no questions  (PDF 276 kB)
1182	Hydroxytyrosol		FDA has no questions  (PDF 203 kB)
1181	Weizmannia coagulans LMG S-31876 spore preparation		FDA has no questions  (PDF 272 kB)
1180	Cellobiose		FDA ceased to evaluate  (PDF 270 kB)
1179	Liquid whole cow milk	GRN 1179 with Amendments (PDF 5.5 MB)	FDA has no questions  (PDF 282 kB)
1178	Rebaudioside I obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside I)		FDA has no questions  (PDF 192 kB)
1177	Bacillus coagulans “Unique IS-2” spore preparation		FDA has no questions  (PDF 214 kB)
1176	Lacto-N-tetraose		FDA ceased to evaluate  (PDF 109 kB)
1175	Lactiplantibacillus plantarum DSM 23881	GRN 1175 with amendments  (PDF 2.9 MB)	FDA has no questions  (PDF 268 kB)
1174	Dry whole goat milk		FDA has no questions  (PDF 221 kB)
1173	Invertase enzyme preparation produced by Trichoderma reesei expressing a gene for invertase from Aspergillus niger		FDA has no questions  (PDF 159 kB)
1172	Liquid milk, either whole or nonfat, combined with lactose and water	GRN 1172 with Amendments (PDF 2.9 MB)	FDA has no questions  (PDF 228 kB)
1171	Collagen polypeptide produced by Escherichia coli K-12 S9188		FDA has no questions  (PDF 248 kB)
1170	Resistant dextrin from tapioca in powder or syrup form		FDA has no questions   (PDF 196 kB)
1169	6'-sialyllactose sodium salt		FDA ceased to evaluate  (PDF 235 kB)
1168	Tigernuts flour		FDA ceased to evaluate  (PDF 98 kB)
1167	Brazzein produced by Komagataella phaffii expressing a gene encoding for brazzein from Pentadiplandra brazzeana	GRN 1167 with amendments  (PDF 2.5 MB)	FDA has no questions  (PDF 293 kB)
1166	Fava bean (Vicia faba L.) protein hydrolysate		FDA has no questions  (PDF 293 kB)
1165	(R)-1,3-butanediol		FDA ceased to evaluate (PDF 200 kB)
1164	A chemically synthesized analog of pediocin PA-1 specific to Listeria monocytogenes		FDA has no questions  (PDF 248 kB)
1162	Fungal oil (≥38% arachidonic acid (ARA)) from Mortierella alpina FJRK-MA01	GRN 1162 (PDF 13.5 MB)	FDA ceased to evaluate (PDF 159 kB)
1163	A preparation containing two bacteriophages (phage) specific to Salmonella enterica		FDA has no questions  (PDF 258 kB)
1161	Triacylglycerol lipase enzyme preparation produced by Candida cylindracea		FDA has no questions  (PDF 258 kB)
1160	Lemna leaf protein	GRN 1160 (PDF 12.4 MB)	FDA ceased to evaluate  (PDF 210 kB)
1159	Heyndrickxia coagulans strain MTCC 25460 spore preparation	GRN 1159 Part 1 (GRN Parts 1-5)  (PDF 13.7 MB) GRN 1159 Part 2 (GRN Part 6)  (PDF 18.1 MB) GRN 1159 Part 3 (GRN Part 7 and amendments) (PDF 7 MB)	FDA has no questions  (PDF 278 kB)
1158	Lactiplantibacillus plantarum DSM 34613	GRN 1158 with Amendments (PDF 8 MB)	FDA has no questions (PDF 222 kB)
1157	2'-fucosyllactose	GRN 1157 with amendments  (PDF 6.5 MB)	FDA has no questions  (PDF 293 kB)
1156	Algal oil (≥35% docosahexaenoic acid from Schizochytrium sp. FJRK-SCH3	GRN 1156 (PDF 7.9 MB)	FDA ceased to evaluate (PDF 199 kB)
1155	1-methylcyclopropene	GRN 1155 with Amendments (PDF 7 MB)	FDA has no questions (PDF 267 kB) Additional correspondence (PDF 266 kB)
1154	Triacylglycerol lipase enzyme preparation produced by Komagataella phaffii expressing the gene encoding lipase from Fusarium oxysporum	GRN 1154 with Amendments (PDF 2.8 MB)	FDA has no questions  (PDF 331 kB)
1153	Pongamia bean oil	GRN 1153 (PDF 12.4 MB)	FDA ceased to evaluate  (PDF 209 kB)
1152	Phoenix oyster mushroom (Pleurotus pulmonarius) mycelia biomass	GRN 1152 (PDF 3.5 MB)	FDA ceased to evaluate  (PDF, 221 kB)
1151	Fava bean protein	GRN 1151 with amendments (PDF 7.7  MB)	FDA has no questions  (PDF 256 kB)
1150	Triaclyglycerol lipase enzyme preparation produced by Trichoderma reesei expressing a gene for triacylglycerol lipase from Thermomyces lanuginosis	GRN 1150 (PDF 3.2 MB)	FDA ceased to evaluate (PDF 183 kB)
1149	High-selenium Saccharomyces cerevisiae yeast	GRN 1149 (PDF 14 MB)	FDA ceased to evaluate (PDF 98 kB)
1148	D-psicose	GRN 1148 with Amendments (PDF 16.6 MB)	FDA has no questions (PDF 247 kB)
1147	Copper(ll) ion	GRN 1147 (PDF 5 MB)	FDA has no questions  (PDF 206 kB)
1146	Nuclease enzyme preparation produced by Bacillus amyloliquefaciens expressing the gene encoding a nuclease from Serratia marcescens	GRN 1146 with Amendments (PDF 2.6 MB)	FDA has no questions (PDF 181 kB)
1145	B-lactoglobulin produced by Aspergillus oryzae strain Ao_st00002	GRN 1145 (PDF 3.9 MB)	FDA has no questions  (PDF 236 kB)
1144	Miracle fruit (Synsepalum dulcificum) powder	GRN 1144 with amendments  (PDF 18.6 MB)	FDA has no questions  (PDF 269 kB)
1143	Bacillus subtilis NRRL 68053	GRN 1143 with Amendments (PDF 5 MB)	FDA has no questions (PDF 222 kB)
1142	Brazzein produced by Komagataella phaffii expressing a gene encoding for brazzein from Pentadiplandra brazzeana	GRN 1142 with Amendments (PDF 7.0 MB)	FDA has no questions (PDF 257 kB) Supplemental Response Letter (PDF 284 kB)
1141	L-α-lycerophosphorylcholine	GRN 1141 with Amendments (PDF 17.3 MB)	At the notifier's request, FDA ceased to evaluate this notice  (PDF 89 kB)
1140	Enzyme-modified steviol glycosides	GRN 1140 with Amendments (PDF 5.2 MB)	FDA has no questions (PDF 251 kB)
1139	Transglutaminase enzyme preparation produced by Bacillus lincheniformis carrying a gene encoding transglutaminase from Streptomyces mobaraenisis	GRN 1139 (PDF 2.5 MB)	FDA has no questions (PDF 202 kB)
1138	Hydroxytyrosol	GRN 1138 (PDF 9.7 MB)	FDA ceased to evaluate (PDF 173 kB)
1137	Protein-sucrose	GRN 1137 with Amendments (PDF 9.4 MB)	FDA has no questions (PDF 188 kB)
1136	Dry whole goat milk	GRN 1136 with Amendments (PDF 8.6 MB)	FDA has no questions (PDF 267 kB)
1135	Galacto-oligosaccharides	GRN 1135 with Amendments (PDF 3.8 MB)	FDA ceased to evaluate (PDF 133 kB)
1134	Bacteriophage preparation specific to Salmonella Enteritidis	GRN 1134 with Amendments (PDF 3.6 MB)	FDA has no questions (PDF 180 kB)
1133	Resistant dextrin from corn	GRN 1133 with Amendments (PDF 7.5 MB)	FDA has no questions (PDF 246 kB)
1132	Hydrolyzed-poultry-protein	GRN 1132 with Amendments (PDF 8.8 MB)	FDA has no questions (PDF 224 kB)
1131	Bacillus subtilis ATCC BS50 PTA-127287	GRN 1131 with Amendments (PDF 6.2 MB)	FDA has no questions (PDF 267 kB)
1130	Lactobacillus rhamnosus CGMCC21225	GRN 1130 with Amendments (PDF 10.1 MB)	FDA has no questions (PDF 248 kB)
1129	Heat-killed Clostridium tyrobutyricum strain ASM#19	GRN 1129 Part 1 (GRN Parts 1 - 3) (PDF 10.7 MB) GRN 1129 Part 2 (GRN Parts 4 - 6) (PDF 16.8 MB) GRN 1129 Part 3 (GRN Part 7, Consensus Statement, Form 3667) (PDF 14. 8 MB) GRN 1129 Part 4 (GRN Amendments) (PDF 19.1 MB)	FDA has no questions (PDF 274 kB)
1128	Algal oil (≥35% docosahexaenoic acid from Schizochytrium sp.	GRN 1128 (PDF 7.4 MB)	FDA ceased to evaluate (PDF 321 kB)
1127	Lactiplantibacillus plantarum ATCC-202195	GRN 1127 with Amendments (PDF 8 MB)	FDA has no questions (PDF 235 kB)
1126	Calcium acetate	GRN 1126 (PDF 3.9 MB)	FDA has no questions (in PDF 193 kB)
1125	Pea protein fermented by shiitake mycelia	GRN 1125 with Amendments (PDF 6.7 MB)	FDA has no questions (PDF 222 kB)
1124	β-Glucans from Hericium erinaceus strain BCRC 35669	GRN 1124 with Amendments (PDF 6.9 MB)	FDA ceased to evaluate (PDF 206 kB)
1123	Sucrose fatty acid esters	GRN 1123 with Amendments (PDF 6.6 MB)	FDA has no questions (PDF 214 kB)
1122	Canola concentrate	GRN 1122 Part 1   (3.3 MB)  GRN 1122 Part 2 - Appendix 1   (9.8 MB)  GRN 1122 Part 3 - Appendix 2-8  (13.1 MB)  GRN 1122 Part 4 - Amendments  (5.5 MB)	FDA has no questions  (PDF 204 kB)
1121	Fructanase enzyme preparation produced by Trichoderma reesei expressing the gene encoding fructanase from Lactobacillus sp.	GRN 1121 (PDF 4.2 MB)	FDA ceased to evaluate (PDF 109 kB)
1120	α-Galactosidase enzyme preparation produced by Aspergillus niger	GRN 1120 with Amendments (PDF 3.9 MB)	FDA has no questions (in PDF 232 kB)
1119	Olea europaea L. leaf extract	GRN 1119 with Amendments (PDF 3.8 MB)	FDA has no questions (PDF 232 kB)
1118	Pyrroloquinoline quinone disodium salt	GRN 1118 with Amendments (PDF 7.4 MB)	FDA has no questions (PDF 356 kB)
1117	Mycelial biomass from Neurospora crassa		FDA has no questions (PDF 246 kB)
1116	Shea stearin	GRN 1116 Part 1 (GRN Parts 1 - 4) (PDF 13 MB) GRN 1116 Part 2 (GRN Parts 5 - 7) (PDF 14 MB) GRN 1116 Part 3 (GRN Appendix A and B) (PDF 8 MB) GRN 1116 Part 4 (GRN Appendix C) (PDF 14 MB) GRN 1116 Part 5 (GRN Appendix C Cont.) (PDF 13 MB) GRN 1116 Part 6 (GRN Appendix D - H) with amendments)  (PDF 8.7 MB)	FDA has no questions (in PDF 164 kB)
1115	Fungal oil (≥40% arachidonic acid (ARA)) from Mortierella alpina strain AF	GRN 1115 with Amendments (PDF 13.1 MB)	FDA has no questions (PDF 256 kB)
1114	Bifodobacterium breve DSM 33444	GRN 1114 with Amendments (PDF 4.7 MB)	FDA has no questions (PDF 141 kB)
1113	Lactobacillus-plantarum-NCIMB-30562	GRN 1113 with Amendments (PDF 3.2 MB)	FDA has no questions (PDF 423 kB)
1112	Limosilactobacillus reuteri strain ATCC PTA-126787 and L. reuteri strain ATCC PTA-126788, in combination, on a 1:1 ratio of colony forming unit (CFU) basis	GRN 1112 Part 1 (GRN, Annex 1-13 with Amendments)   (10.5 MB)  GRN 1112 Part 2 - Annex 14a-b (10.2 MB)  GRN 1122 Part 3 - Annex 14c  (11.2 MB)  GRN 1122 Part 4 - Annex 14d  (10.4 MB)	FDA has no questions (PDF 235 kB)
1111	Endo-1, 4-B-xylanase enzyme preparation produced by Bacillus subtilis expressing the gene encoding xylanase from B. subtilis	GRN 1111 (PDF 3 MB)	FDA ceased to evaluate (PDF 136 kB)
1110	Polygalacturonase enzyme preparation produced by Trichoderma reesei expressing a gene encoding a polygalacturonase from Aspergillus kawachii	GRN 1110 (PDF 4 MB)	FDA ceased to evaluate (PDF 185 kB)
1109	β-agarase enzyme preparation produced by Streptomyces coelicolor	GRN 1109 with Amendments (PDF 11.8 MB)	FDA has no questions (PDF 174 kB)
1108	Lactiplantibacillus plantarum strain MCC 0537	GRN 1108 with Amendments (PDF 5.7 MB)	FDA has no questions (PDF 209 kB)
1107	Bifidobacterium longum subsp. infantis strain LMG 11588	GRN 1107 with Amendments (PDF 2.8 MB)	FDA has no questions (PDF 241 kB)
1106	Rebaudioside I obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside I)	GRN 1106 with Amendments (PDF 4.8 MB)	FDA has no questions (PDF 277 kB)
1105	Polyglycerol polyricinoleic acid	GRN 1105 with Amendments (PDF 7.32 MB)	FDA has no questions (PDF 225 kB)
1104	Egg-white protein produced by Komagataella phaffii ATCC GSD-1235	GRN 1104 with Amendments (PDF 5.2 MB)	FDA has no questions (PDF 264 kB)
1103	Canola protein isolate		FDA has no questions  (PDF 462 kB) Correction Letter  (PDF 272 kB)
1102	Invertase enzyme preparation produced by Trichoderma reesei expressing a gene for invertase from Aspergillus niger	GRN 1102 (PDF 6.4 MB)	FDA ceased to evaluate (PDF 132 kB)
1101	Dried biomass of Chlamydomonas reinhardtii strain TAl114	GRN 1101 (PDF 4 MB)	FDA ceased to evaluate (PDF 161 kB)
1100	Fractioned whey protein concentrate containing 41% alpha-lactalbumin	GRN 1100 with Amendments (PDF 2.8 MB)	FDA has no questions (PDF 259 kB)
1098	Chickpea protein concentrate	GRN 1098 with Amendments (PDF 12.1 MB)	FDA has no questions (PDF 273 kB)
1099	3-fucosyllactose	GRN 1099 with Amendments (PDF 2.6 MB)	FDA has no questions (PDF 292 kB)
1097	Maltogenic alpha-amylase enzyme preparation produced by Escherichia coli expressing a gene encoding a maltogenic alpha-amylase from Geobacillus stearothermophilus	GRN 1097 with Amendments (PDF 9 MB)	FDA has no questions (PDF 247 kB)
1096	Saccharomyces cerevisiae strain OYR-243	GRN 1096 with Amendments (PDF 13.1 MB)	FDA has no questions (PDF 212 kB)
1095	Baillus subtilis strain ATCC AAN000002 spore preparation	GRN 1095 with Amendments (PDF 7.4 MB)	FDA has no questions (PDF 286 kB)
1094	Saccharomyces cerevisiae strain BY-989 expressing a gene encoding a carbon-sulfur lyase from Citrobacter freundii	GRN 1094 with Amendments (PDF 9.1 MB)	FDA has no questions (PDF 180 kB)
1093	Lacticaseibacillus rhamnosus IDCC 3201	GRN 1093 with Amendments (PDF 5.5 MB)	FDA has no questions (PDF 265 kB)
1092	Bifidobacterium animalis subsp. lactis IDCC 4301	GRN 1092 with Amendments (PDF 20.2 MB)	FDA has no questions (PDF 267 kB)
1091	2'-fucosyllactose	GRN 1091 with Amendments (PDF 2.1 MB)	FDA has no questions (PDF 272 kB)
1090	Bifidobacterium bifidum strain NITE BP-31	GRN 1090 with Amendments (PDF 9.3 MB)	FDA has no questions (PDF 209 kB)
1089	Lactobacillus gasseri strain NCIMB 30370	GRN 1089 with Amendments (PDF 6.4 MB)	FDA has no questions (PDF 244 kB)
1088	Lactococcus lactis strain KCTC 11865BP	GRN 1088 with Amendments (PDF 11.3 MB)	FDA has no questions (PDF 273 kB)
1087	Streptococcus thermophilus strain KCTC 11870BP	GRN 1087 with Amendments (PDF 10.8 MB)	FDA has no questions (PDF 234 kB)
1086	Lactobacillus plantarium CBT LP3	GRN 1086 (PDF 5 MB)	FDA has no questions (PDF 291 kB)
1085	Lactobacillus casei strain KCTC 12398BP	GRN 1085 (PDF 2.9 MB)	FDA has no questions (PDF 313 kB)
1084	Lactobacillus rhamnosus CBT LR5	GRN 1084 with Amendments (PDF 9.8 MB)	FDA has no questions (PDF 247 kB)
1083	Lactobacillus acidophilus CBT LA1	GRN 1083 with Amendments (PDF 18.8 MB)	FDA has no questions (PDF 218 kB)
1082	Bifidobacterium lactis strain KCTC 11904BP	GRN 1082 with Amendments (PDF 10.1 MB)	FDA has no questions (PDF 267 kB)
1081	Bifidobacterium infantis strain KCTC 11859BP	GRN 1081 with Amendments (PDF 13 MB)	FDA has no questions (PDF 251 kB)
1080	Bifidobacterium breve strain KCTC 12201BP	GRN 1080 with Amendments (PDF 7.7 MB)	FDA has no questions (PDF 241 kB)
1079	Bifidobacterium bifidum strain KCTC 12200BP	GRN 1079 Part 1 (PDF 7.5 MB) GRN 1079 Part 2 Amendments (PDF 13.3 MB) GRN 1079 Part 3 Amendments (PDF 6.8 MB)	FDA has no questions (PDF 240 kB)
1078	Bifidobacterium bifidum strain KCTC 12199BP	GRN 1078 with Amendments (PDF 7.5 MB)	FDA has no questions (PDF 239 kB)
1077	Oat polar lipid extract	GRN 1077 with Amendments (PDF 6.6 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 164 kB)
1076	Galacto-oligosaccharides		FDA has no questions (PDF 245 kB) Supplemental Response Letter (PDF 253 kB)
1075	6'-sialyllactose sodium salt	GRN 1075 with Amendments (PDF 6.3 MB)	FDA has no questions (PDF 286 kB)
1074	3'-sialyllactose sodium salt	GRN 1074 with Amendments (PDF 7 MB)	FDA has no questions (PDF 383 kB)
1073	Corn bran arabinoxylan	GRN 1073 with Amendments (PDF 10.4 MB)	FDA has no questions (PDF 247 kB)
1072	Lemnaceae fiber	GRN 1072 with Amendments (PDF 16 MB)	FDA ceased to evaluate (PDF 229 kB)
1071	Glucose oxidase enzyme preparation produced by Saccharomyces cerevisiae expressing a gene encoding glucose oxidase from Aspergillus niger	GRN 1071 with Amendments (PDF 2.8 MB)	FDA has no questions (PDF 169 kB)
1070	Preparations containing six bacteriophages (phage) specific to Salmonella enterica	GRN 1070 with Amendments (PDF 7.3 MB)	FDA has no questions (PDF 279 kB)
1069	Corn protein	GRN 1069 with Amendments (PDF 9.0 MB)	FDA has no questions (PDF 247 kB)
1068	Lacto-N-tetraose	GRN 1068 with Amendments (PDF 2.0 MB)	FDA has no questions (PDF 302 kB)
1067	Lacto-N-neotetraose	GRN 1067 with Amendments (PDF 7.6 MB)	FDA has no questions (PDF 306 kB)
1066	Carnobacterium divergens strain M35	GRN 1066 with Amendments (PDF 10.6 MB)	FDA has no questions (PDF 222 kB)
1065	Anaerobutyricum soehngenii CH106	GRN 1065 with Amendments (PDF 7.4 MB)	FDA has no questions (PDF 222 kB)
1064	Whole fruit pomegranate extract	GRN 1064 with Amendments (PDF 9.5 MB)	FDA has no questions (PDF 258 kB)
1063	Weissella cibaria CMU	GRN 1063 (PDF 27.0 MB)	FDA has no questions (PDF 254 kB)
1062	Saccharomyces cerevisiae strain OYR-185	GRN 1062 with Amendments (PDF 19.2 MB)	FDA has no questions (PDF 207 kB)
1061	Deactivate alkaline serine protease produced by Bacillus licheniformis strain CICC 10266	GRN 1061 (PDF 7.1 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 249 kB)
1060	2'-fucosyllactose	GRN 1060 with Amendments (PDF 9.9 MB)	FDA has no questions (PDF 333 kB)
1059	Lacto-N-neotetraose	GRN 1059 with Amendments (PDF 2.8 MB)	FDA has no questions (PDF 288 kB)
1058	Polyvinyl alcohol	GRN 1058 with Amendments (PDF 15.8 MB)	FDA has no questions (PDF 283 kB)
1057	D-psicose	GRN 1057 with Amendments (PDF 14.5 MB)	FDA has no questions (PDF 298 kB)
1056	B-lactoglobulin produced by Komagataella phaffii strain "yRMK-66"	GRN 1056 with Amendments (PDF 8.2 MB)	FDA has no questions (PDF 291 kB)
1055	Xylanase enzyme preparation produced by Bacillus licheniformis strain expressing the xylanase gene from Chryseobacterium	GRN 1055 with Amendments (PDF 3.0 MB)	FDA has no questions (PDF 265 kB)
1054	Glucose oxidase enzyme preparation produced by Aspergillus niger expressing the gene encoding glucose oxidase from A. niger	GRN 1054 with Amendments (PDF 5.1 MB)	FDA has no questions (PDF 270 kB)
1053	6'-sialyllactose sodium salt	GRN 1053 with Amendments (PDF 15.4 MB)	FDA has no questions (PDF 266 kB)
1052	3'-sialyllactose sodium salt	GRN 1052 with Amendments (PDF 12.3 MB)	FDA has no questions (PDF 292 kB)
1051	2'-Fucosyllactose	GRN 1051 (PDF 18 MB) GRN 1051 Part 2 Amendments (PDF 4.9 MB)	FDA has no questions (PDF 298 kB)
1050	High 2-palmitic acid vegetable oil	GRN 1050 with Amendments (PDF 7.2 MB)	FDA ceased to evaluate (PDF 175 kB)
1049	Medium-chain triacylglycerols	GRN 1049 with Amendments (PDF 10.8 MB)	FDA has no questions (PDF 249 kB)
1048	Aminopeptidase enzyme preparation produced by Trichoderma reesei expressing a gene encoding an aminopeptidase from Aspergillus clavatus	GRN 1048 with Amendments (PDF 7.5  MB)	FDA has no questions (PDF 227 kB)
1047	Lipase produced by Saccharomyces cerevisiae	GRN 1047 with Amendments (PDF 3.3 MB)	FDA has no questions (in PDF 164 kB)
1046	Collagenase enzyme preparation from genetically modified Streptomyces violaceoruber expressing a collagenase gene	GRN 1046 with Amendments (PDF 8.9 MB)	FDA has no questions (PDF 219 kB)
1045	Resistant dextrin from tapioca	GRN 1045 with Amendments (PDF 5.1 MB)	FDA has no questions (in PDF 250 kB)
1044	Calcium disodium ethylenediaminetetraacetic acid	GRN 1044 (PDF 4.9 MB)	FDA ceased to evaluate (PDF 118 kB)
1043	Cetylated fatty acids	GRN 1043 with Amendments (PDF 6.9 MB)	FDA has no questions (PDF 189 kB)
1042	Menaquinone-7 derived from a specific strain of Bacillus subtilis natto	GRN 1042 (PDF 17 MB)	FDA ceased to evaluate (PDF 188 kB)
1041	Dry whole milk	GRN 1041 with Amendments (PDF 2.0 MB)	FDA has no questions (PDF 152 kB)
1040	2'-fucosyllactose	GRN 1040 (PDF 5.7 MB)	FDA ceased to evaluate (PDF 116 kB)
1039	Lactase enzyme preparation produced by Aspergillus oryzae	GRN 1039 with Amendments (PDF 5.9 MB)	FDA has no questions (PDF 195 kB)
1038	Preparation containing six bacteriophages (phage) specific to Salmonella enterica spp. serovars	GRN 1038 with Amendments (PDF 20.4 MB)	FDA has no questions (PDF 333 kB)
1037	3-fucosyllactose	GRN 1037 with Amendments (PDF 7 MB)	FDA has no questions (PDF 287 kB)
1036	Complexation products of iron with sodium citrate	GRN 1036 with Amendments (PDF 1.2 MB)	FDA has no questions (PDF 285 kB)
1035	Lacto-N-fucopentaose l with 2'-fucosyllactose	GRN 1035 with Amendments (PDF 14.9 MB)	FDA has no questions (PDF 288 kB)                          Correction Letter  (PDF 138 kB)
1034	2'-fucosyllactose	GRN 1034 with Amendments (PDF 3 MB)	FDA has no questions (PDF 258 kB)
1033	Hydrolyzed Saccharomyces cerevisiae	GRN 1033 with Amendments (PDF 3 MB)	FDA has no questions (PDF 178 kB)
1032	D-β-hydroxybutyrate	GRN 1032 with Amendments (PDF 7.08 MB)	FDA has no questions (PDF 214 kB)
1031	Barley and rice protein hydrolysate	GRN 1031 with Amendments (PDF 4 MB)	FDA has no questions (PDF 219 kB)
1030	Cellulase enzyme preparation produced by Aspergillus niger genetically engineered to express a cellulase gene from Trichoderma reesei	GRN 1030 with Amendments (PDF 8 MB)	FDA has no questions (PDF 286 kB)
1029	D-psicose	GRN 1029 with Amendments (PDF 11.1 MB)	FDA has no questions (PDF 255 kB)
1028	Metschnikowia pulcherrima DANMET-A and M. fructicola DANMET-B	GRN 1028 (PDF 3.2 MB)	FDA ceased to evaluate (PDF 306 kB)
1027	Miracle fruit (Synsepalum dulcificum) powder	GRN 1027 (PDF 2.3 MB)	FDA ceased to evaluate (PDF 137 kB)
1026	Silk fibroin derived from Bombyx mori cocoons	GRN 1026 Part 1 with Appx A-D (PDF 9.6 MB) GRN 1026 Part 2 Appx. E-G.1 (PDF 11.6 MB) GRN 1026 Part 3  Appx. G.2, G.3, G.4 (PDF 13.1 MB) GRN 1026 Part 4  Appx. G.4 App. A-F (PDF 14.8 MB) GRN 1026 Part 5  Appx. G.4 App. G-P (PDF 11.0 MB) GRN 1026 Part 6 Appx. G.4 App. P-Appx H (PDF 17.1 MB) GRN 1026 Part 7  Appx. I-K and amendments (PDF 5.9 MB)	FDA has no questions (PDF 185 kB)
1025	Pepsin A enzyme preparation produced by Pichia pastoris to overexpress the gene pepsin A	GRN 1025 with Amendments (PDF 2.9 MB)	FDA has no questions (PDF 318 kB)
1024	D-psicose	GRN 1024 with Amendments (PDF 15.6 MB)	FDA has no questions (PDF 253 kB)
1023	Monosodium L-5-methyltetrahydrofolate	GRN 1023 Part 1 (PDF 17 MB) GRN 1023 Part 2 with Amendments (PDF 20 MB)	FDA ceased to evaluate (PDF 85 kB)
1022	Streptococcus salivarius DB-B5	GRN 1022 with Amendments (PDF 16.4 MB)	FDA has no questions (PDF 177 kB)
1021	Transglutaminase enzyme preparation produced by Streptomyces mobaraensis strain M2020197	GRN 1021 with Amendments (PDF 7.3 MB)	FDA has no questions (PDF 395 kB) Supplemental Response Letter (PDF 274 kB)
1020	Protein from Helianthus annuus (sunflower protein)	GRN 1020 with Amendments (PDF 4.5 MB)	FDA ceased to evaluate (PDF 101 kB)
1019	Agave mixed fructans from Agave tequilana Weber var. azul	GRN 1019 with Amendments (PDF 3.5 MB)	FDA has no questions (in PDF 271 kB)
1018	Carbon monoxide	GRN 1018 with Amendments (PDF 4.2 MB)	FDA has no questions (PDF 254 kB)
1017	Lacto-N-tetraose	GRN 1017 (PDF 3.3 MB)	FDA has no questions (PDF 245 kB)
1016	6’-sialyllactose sodium salt	GRN 1016 with Amendments (PDF 3.9 MB)	FDA has no questions (PDF 237 kB)
1015	3’-sialyllactose sodium salt	GRN 1015 with Amendments (PDF 4.0 MB)	FDA has no questions (PDF 234 kB)
1014	2'-fucosyllactose	GRN 1014 with Amendments (PDF 5.5 MB)	FDA has no questions (PDF 295 kB)
1013	Lactobacillus rhamnosus DSM 33156	GRN 1013 (PDF 18.0 MB)	FDA has no questions (PDF 310 kB)
1012	Powdered sap from Angelica keiskei (ashitaba) containing 8% chalcones (ashitaba sap)	GRN 1012 (PDF 5.1 MB)	FDA ceased to evaluate (PDF 107 kB)
1011	Alpha-amylase enzyme preparation produced by Bacillus subtilis strain AR-651 expressing the gene encoding alpha-amylase from Thermoactinomyces vulgaris	GRN 1011 with Amendments (PDF 2.6 MB)	FDA has no questions (PDF 294 kB)
1010	Rebaudioside M obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni)	GRN 1010 (PDF 5.1 MB)	FDA has no questions (PDF 411 kB)
1009	Water-soluble palm fruit extract	GRN 1009 (PDF 1.0 MB)	FDA ceased to evaluate (PDF 128 kB)
1008	Algal oil (≥45% docosahexaenoic acid) from Aurantiochytrium limacinum TKD-1	GRN 1008 with Amendments (PDF 2.7 MB)	FDA has no questions (PDF 165 kB)
1007	Bacillus-subtilis Strain R0179	GRN 1007 Part 1 (PDF 15.2 MB) GRN 1007 Part 2 (PDF 12.82 MB) GRN 1007 Part 3 (PDF 12.93  MB)                       GRN 1007 Part 4 (PDF 11.84 MB) GRN 1007 Part 5 (PDF 17.96 MB) GRN 1007 Part 6  (PDF 11.01 MB) GRN 1007 Part 7 (PDF 6.04 MB)	FDA ceased to evaluate (PDF 184 kB)
1006	Short-chain fructooligosaccharides	GRN 1006 with Amendments (PDF 2.6 MB)	FDA has no questions (PDF 177 kB) Additional correspondence  (PDF 250 kB)
1005	Beta Lactoglobulin from cow milk	GRN 1005 with Amendments (PDF 4.9 MB)	FDA ceased to evaluate (PDF 93 kB)
1004	Maltosyltrehalose syrup	GRN 1004 with Amendments (PDF 13 MB)	FDA ceased to evaluate (PDF 84 kB)
1003	Bifidobacterium longum subsp. infantis M-63	GRN 1003 with Amendments (PDF 2.2 MB)	FDA has no questions (PDF 74 kB)
1002	Bifidobacterium breve strain MCC1274	GRN 1002 with Amendments (PDF 3.6 MB)	FDA has no questions (PDF 221 kB)
1001	Myoglobin preparation from a strain of Pichia pastoris expressing the myoglobin gene from Bos taurus	GRN 1001 with Amendments (PDF 14.6 MB)	FDA has no questions (PDF 374 kB)
1000	Phycocyanin-rich extract of Galdieria sulphuraria (G. sulphuraria strain "FCC3424")	GRN 1000 (PDF 2 MB)	FDA ceased to evaluate (PDF 160 kB)
999	Enzyme-modified steviol glycosides	GRN 999 (PDF 5.2 MB)	FDA has no questions (PDF 171 kB)
998	Corn bran arabinoxylan	GRN 998 with Amendments (PDF 3.9 MB)	FDA ceased to evaluate (PDF 100 kB)
997	Bacillus subtilis strain BS-MB40 PTA-122264 spore preparation	GRN 997 with Amendments (PDF 6 MB)	FDA has no questions (PDF 140 kB) Supplemental Response Letter (PDF 193 kB)   Supplemental Response Letter 2 (PDF 165 kB)
996	Synthetic amorphous silica	GRN 996 with Amendments (PDF 4.6 MB)	FDA has no questions (PDF 137 kB)
995	beta-glucans from Antrodia cinnamomea strain ATCC 200183	GRN 995 with Amendments (PDF 5.4 MB)	FDA has no questions (PDF 162 kB)
994	Miracle fruit (Synsepalum dulcificum) in pulp, powder or protein forms	GRN 994 (PDF 2.0 MB)	FDA ceased to evaluate (PDF 140 kB)
993	L-carnitine-L-tartrate	GRN 993 with Amendments (PDF 3.0 MB)	FDA has no questions (PDF 149 kB)
992	White mulberry (Morus alba Linn) leaf extract	GRN 992 with Amendments	FDA ceased to evaluate (PDF 96 kB)
991	Chitonase enzyme preparation produced by Bacillus subtilis	GRN 991 with Amendments (PDF 14.3 MB)	FDA has no questions (PDF 225 kB)
990	Short-chain fructooligosaccharides	GRN 990 with Amendments (PDF 9.0 MB)	FDA has no questions (PDF 118 kB)
989	Bacillus subtilis expressing a modified gene encoding a variant of the wild-type subtilisin from B. clausii	GRN 989 with Amendments (PDF 6.6 MB)	FDA has no questions (PDF 144 kB)
988	Lactobacillus fermentum LfQi6	GRN 988 with Amendments (PDF 9.2 MB)	FDA has no questions (PDF 137 kB)
987	2'-fucosyllactose	GRN 987 with Amendments (PDF 18 MB)	FDA ceased to evaluate (PDF 235 kB)
986	Chlorella sorokiniana powder and C. sorokiniana micro powder	GRN 986 (PDF 3.5 MB)	FDA has no questions (PDF 148 kB)
985	Bifidobacterium longum subsp. infantis strain ATCC SD 6720	GRN 985 with Amendments (PDF 11.6 MB)	FDA has no questions (PDF 338 kB)
984	Wolffia globosa	GRN 984 with Amendments (PDF 5.4 MB)	FDA ceased to evaluate (PDF 142 kB)
983	Purified steviol glycosides from the leaves of Stevia rebaudiana (Bertoni)	GRN 983 (PDF 4.4 MB)	FDA has no questions (PDF 180 kB)
982	Polygalacturonase enzyme preparation produced by Aspergillus oryzae expressing a polygalacturonase gene from A. tubingensis Mosseray	GRN 982 (PDF 4.0 MB)	FDA has no questions (PDF 154 kB)
981	Sterol esterase enzyme preparation produced by Trichoderma reesei expressing a gene encoding sterol esterase from Melanocarpus albomyces	GRN 981 with Amendments (PDF 4.1 MB)	FDA has no questions (PDF 255 kB)
980	Dry whole milk	GRN 980 with Amendments (PDF 14.4 MB)	FDA has no questions (PDF 124 kB)
979	Pectin esterase enzyme preparation produced by Aspergillus oryzae expressing a pectin esterase gene from A. tubingensis	GRN 979 with Amendments (PDF 2.7 MB)	FDA has no questions (PDF 143 kB)
978	Hydrolyzed aqueous olive pulp extract	GRN 978 with Amendments (PDF 4.1 MB)	FDA has no questions (PDF 256 kB)
977	D-tagatose produced via novel enzymatic cascade	GRN 977 with Amendments (PDF, 4.0 MB)	FDA has no questions (PDF 152 kB)
976	Sodium hyaluronate	GRN 976 (PDF 5.0 MB)	FDA ceased to evaluate (PDF 184 kB)
975	Maltogenic alpha-amylase enzyme preparation produced by Bacillus licheniformis carrying the gene coding for maltogenic alpha-amylase from Geobacillus stearothermophilus	GRN 975 with Amendments (PDF, 823 kB)	FDA has no questions (PDF 313 kB)
974	Maltogenic alpha-amylase enzyme preparation by Bacillus subtilis	GRN 974 (PDF 1.8 MB)	FDA has no questions (PDF 310 kB)
973	Maple wood fiber	GRN 973 (PDF 3.1 MB) GRN 973  Amendments (PDF 2.2 MB)	FDA ceased to evaluate (PDF 169 kB)
972	Pectin hydrolysate from carrot pomace	GRN 972 (PDF 4.0 MB)                               GRN 972 Amendments (PDF 2.4 MB)	FDA has no questions (PDF 124 kB)
971	Bacillus clausii strain 088AE spore preparation	GRN 971 with Amendments (PDF 9.2 MB)	FDA has no questions (PDF 150 kB)
970	Enzyme-modified steviol glycosides	GRN 970 (PDF 4.5 MB)	FDA has no questions (PDF 225 kB)
969	Bacillus subtilis "Bss-19" spore preparation	GRN 969 with Amendments (PDF 4.8 MB)	FDA has no questions (PDF 226 kB)
968	Rebaudioside B	GRN 968 with Amendments (PDF 3.7 MB)	FDA has no questions (PDF 227 kB)
967	Soluble egg-white protein produced by Pichia pastoris strain "DFB-003"	GRN 967 (PDF 23.13 MB)                             GRN 967  Amendments (PDF 2.1 MB)	FDA has no questions (PDF 306 kB)
966	Preparations containing three to eight bacteriophages specific to Campylobacter jejuni	GRN 966 (PDF 13.5 MB)	FDA has no questions (PDF 313 kB)
965	Arabinase enzyme preparation produced by Aspergillus tubingensis	GRN 965 (PDF 1.8 MB)                                GRN 965  Amendments (PDF 24 MB)	FDA has no questions (PDF 500 kB)
964	Lysophospholipase enzyme preparation from Aspergillus niger produced by Trichoderma reesei	GRN 964 (PDF 1.9 MB)                                GRN 964  Amendments (PDF 1.5 MB)	FDA has no questions (PDF 158 kB)
963	Fungal oil (≥40% arachidonic acid) from Mortierella alpine	GRN 963 (PDF 17.3 MB)                       GRN 963 with Amendments (PDF 1.1 MB)	FDA has no questions (PDF 424 kB)
962	Rice bran wax	GRN 962 with Amendments (PDF 12 MB)	FDA ceased to evaluate (PDF 137 kB)
961	Beta-glucan derived from Agrobacterium sp. CCTCC No. M2010020	GRN 961 with Amendments (PDF 5.1 MB)	FDA ceased to evaluate (PDF 246 kB)
960	Hypromellose acetate succinate	GRN 960 (PDF 6.6 MB)	FDA has no questions (PDF 126 kB)
959	Iron milk proteinate	GRN 959 (PDF 1.9 MB)	FDA has no questions (PDF 213 kB)
958	Fungal oil (≥40% arachidonic acid) from Mortierella alpina strain AF	GRN 958 with Amendments (PDF 1.6 MB)	FDA ceased to evaluate (PDF 91 kB)
957	Lactobacillus johnsonii strain ATCC PTA-124205	GRN 957 (PDF 15 MB)	FDA has no questions (PDF 171 kB)
956	Bacillus subtilis PLSSC (ATCC SD 7280)	GRN 956 with Amendments (PDF 1.5 MB)	FDA has no questions (PDF 130 kB)
955	Bacillus subtilis strain BS-MB40 PTA-122264 spore preparation	GRN 955 with Amendments (PDF 3 MB)	FDA has no questions (PDF 244 kB)                     Supplemental Response Letter (PDF 231 kB)
954	Fibrillated cellulose	GRN 954 with Amendments (PDF 2.7 MB)	FDA ceased to evaluate (PDF 111 kB)
953	Lactobacillus plantarum strain CECT 7527, CECT 7528 and CECT 7529	GRN 953 Amendment (PDF 4.16 MB)	FDA has no questions (PDF 279 kB)
952	Bifidobacterium animalis subsp. lactis strain AD011	GRN 952 with Amendments (PDF 3.09 MB)	FDA has no questions (PDF 159 kB)
951	3-fucosyllactose	GRN 951 with Amendments (PDF 5.7 MB)	FDA has no questions (PDF 272 kB)
950	Bifidobacterium longa subsq. infantis DSM 33361	GRN 950 Part 1 (PDF 11.5 MB) GRN 950 Part 2 (PDF 8.9 MB) GRN 950 Part 3 with Amendments (PDF 8.11 MB)	FDA has no questions (PDF 281 kB)
949	Bacillus coagulans strain DSM 17654	GRN 949 (PDF 21.4 MB)	FDA has no questions (PDF 556 kB)
948	Enzyme-treated pea protein	GRN 948 (PDF 2.2 MB)	FDA has no questions (PDF 150 kB)
947	Cacao pulp, juice and juice concentrate	GRN 947 (PDF 2.93 MB)	FDA has no questions (PDF 145 kB)
946	Lactobacillus plantarum strain DSM 33452	GRN 946 with Amendments (PDF 3.7 MB)	FDA has no questions (PDF 91 kB)
945	Fungal protein from Fusarium sp. mycelia	GRN 945 (PDF 2.7 MB)	FDA has no questions (PDF 141 kB)
944	Rice protein hydrolysate	GRN 944 with Amendments (PDF 4.6 MB)	FDA has no questions (PDF 280 kB)
943	Citrus fiber from the peels of oranges, lemons or limes	GRN 943 (PDF 3.5 MB)	FDA has no questions (PDF 201 kB) Supplemental Response Letter (PDF 234 kB)
942	Whey permeate	GRN 942 (PDF 919 kB)	FDA ceased to evaluate (PDF 188 kB)
941	Oat polar lipid extract	GRN 941 (PDF 3.7 MB)	FDA ceased to evaluate (PDF 124 kB)
940	Phospholipase A2 enzyme from Sus scrota (wild pig) produced by Yarrowia lipolytica	GRN 940 (PDF 6.1 MB)	FDA has no questions (PDF 540 kB)
939	Sunflower lecithin	GRN 939 Part 1 (PDF 10.2 MB) GRN 939 Part 2 with Amendments (PDF 18.8 MB)	FDA has no questions (PDF 109 kB)
938	Pichia kluyveri DSM 33235	GRN 938 (PDF 7.6 MB)	FDA has no questions (PDF 147 kB)
937	Staphylococcus carnosus DSM 25010	GRN 937 (PDF 3.5 MB)	FDA has no questions (PDF 189 kB)
936	Leuconostoc carnosum DSM 32756	GRN 936 (PDF 1.8 MB)	FDA has no questions (PDF 212 kB)
935	L-carnitine-L-tartrate	GRN 935 (PDF 3.2 MB)	FDA ceased to evaluate (PDF 242 kB)
934	Algal oil (>35% docosahexanoic acid (DHA)) derived from Schizochytrium sp. strain CABIO-A-2	GRN 934 (PDF 2.0 MB)	FDA has no questions (PDF 214 kB) Supplemental Response Letter (PDF 219 kB)
933	Algal oil (>36% docosahexaenoic acid) from Schizochytrium sp. strain DHF	GRN 933 (PDF 5.1 MB)	FDA has no questions (PDF 757 kB)
932	2'-Fucosyllactose	GRN 932 (PDF 10.0 MB) GRN 932 with Amendments (PDF 3.6 MB)	FDA has no questions (PDF 223 kB)
931	Creatine monohydrate	GRN 931 (PDF 3.1 MB)	FDA has no questions (PDF 437 kB)
930	Silk protein derived from bombyx cocoons	GRN 930 Part 1 (PDF 18 MB) GRN 930 Part 2 (PDF 4.5 MB) GRN 930 Part 3 (PDF 6.8 MB)	FDA ceased to evaluate (PDF 125 kB)
929	2'-fucosyllactose	GRN 929 (PDF 3.6 MB) GRN 929 with Amendments (PDF 7 MB)	FDA has no questions (PDF 267 kB)
928	Dried Saccharomyces cerevisiae yeast fermentate	GRN 928 (PDF 12 MB) GRN 928 with Amendments (PDF 3.7 MB)	FDA has no questions (PDF 248 kB)
927	Polyvinyl alcohol	GRN 927 (PDF 4.0 MB) GRN 927 with Amendments (PDF 5.2 MB)	FDA has no questions (PDF 205.85 kB)
926	Soluble rice flour	GRN 926 (PDF 6.32 MB)	FDA has no questions (PDF 434 kB) Supplemental Response Letter (PDF 169 kB)
925	3'-Fucosyllactose	GRN 925 (PDF 4.13 MB)	FDA has no questions (PDF 190 kB)
924	2'-Fucosyllactose	GRN 924 with Amendments (PDF 2.4 MB)	FDA ceased to evaluate (PDF 242 kB)
923	Lacto-N-tetraose	GRN 923 with Amendments (PDF 2.3 MB)	FDA has no questions (PDF 187 kB)
922	6'-sialyllactose sodium salt	GRN 922 with Amendments (PDF 1.69 MB)	FDA has no questions (PDF 243 kBkB
921	3'-sialyllactose sodium salt	GRN 921 (PDF 2.2 MB)	FDA has no questions (PDF 771 kB)
920	Thaumatin II	GRN 920 (PDF 5.8 MB)	FDA has no questions (PDF 170 kB)
919	Lacto-N-neotetraose	GRN 919 (PDF 1.4 MB)	FDA has no questions (PDF 353 kB)
918	Partially defatted almond protein flour	GRN 918 (PDF 1.4 MB) GRN 918 with Amendments (PDF 10.0 MB)	FDA has no questions (PDF 206 kB)
917	Preparation containing three bacterial phages specific to Salmonella	GRN 917 (PDF 3.1 MB)	FDA has no questions (PDF 539.77 kB)
916	Dihydroquercetin	GRN 916 with Amendments (PDF 11 MB)	FDA has no questions (PDF 245 kB)
915	Calcium L-methylfolate	GRN 915 (PDF 3.8 MB)	FDA has no questions (PDF 217 kB)
914	Alpha-linolenic acid diacylglycerol	GRN 914 with Amendments (PDF 3.9 MB)	FDA has no questions (PDF 175 kB)
913	Algal oil (minimum 35% DHA)	GRN 913 (PDF 4.1 MB)	FDA has no questions (PDF 906 kB)
912	Trehalose	GRN 912 (PDF 2.5 MB)	FDA ceased to evaluate (PDF 140 kB)
911	Rebaudioside I	GRN 911 (PDF 14.6 MB)	FDA has no questions (PDF 208 kB)
910	Thaumatin II produced in Nicotiana benthamiana	GRN 910 (PDF 2.8 MB)	FDA has no questions (PDF 541 kB)
909	Whey protein containing 41% alpha-lactalbumin	GRN 909 Amendment (PDF 1.1 MB)	FDA ceased to evaluate (PDF 123 kB)
908	Lipase from Penicillium camemberti	GRN 908 Amendment (PDF 2.1 MB)	FDA has no questions (PDF 184 kB)
907	Wheat seed oil	GRN 907 (PDF 10.45 MB)	FDA has no questions (PDF 593 kB)
906	Wheat polar lipids	GRN 906 (PDF 3.8 MB)	FDA has no questions (PDF 518 kB)
905	Bacilllus subtilis SG188	GRN 905 (PDF 4.4 MB)	FDA has no questions (PDF 659 kB)
904	Fungal protein from fermented Fusarium sp. mycelia	GRN 904 Amendment (PDF 9.2 MB)	FDA has no questions (PDF 956 kB)
903	Quillaia extract type 2	GRN 903 (PDF 2.4 MB) GRN 903 Amendment (PDF 8.4 MB)	FDA has no questions (PDF 194 kB)
902	Neohesperidin dihydrochalcon	GRN 902 (PDF 9  MB)	FDA has no questions (PDF 408 kB)
901	Glucosyl hesperidin	GRN 901 (PDF 13 MB) GRN 901 Amendment (PDF 2.5 MB)	FDA has no questions (PDF 670 kB)
900	Corn oil	GRN 900 (PDF 5.2 MB)	FDA has no questions (PDF 539 kB)
899	Citric acid esters of mono- and diglycerides	GRN 899 (PDF 2.1 MB)	FDA has no questions (PDF 624 kB)
898	Dried milk fat	GRN 898 (PDF 2.5 MB) GRN 898 Amendment (PDF 2.5 MB)	FDA has no questions (PDF 650 kB)
897	2'-O-fucosyllactose	GRN 897 (PDF 1.8 MB)	FDA has no questions (PDF 715 kB)
896	Alpha-galacto-oligosaccharides	GRN 896 with Amendments (PDF 5.9 MB)	FDA has no questions (PDF 202 kB)
895	Lacto-N-neotetraose	GRN 895 (PDF 3.1 MB)	FDA has no questions (PDF 858 kB)
894	White mulberry leaf extract	GRN 894 (PDF 6 MB)	FDA ceased to evaluate (PDF 200 kB)
893	Allulose	GRN 893 with Amendments (PDF 10.6 MB)	FDA ceased to evaluate (PDF 58 kB)
892	Refined shea butter	GRN 892 (PDF 11.8 MB)	FDA ceased to evaluate (PDF 162 kB)
891	Cellulase produced by Trichoderma reesei	GRN 891 with Amendments (PDF 2.1 MB)	FDA has no questions (PDF 512 kB)
890	Corn oil derived from distillers grains	GRN 890 Part 1 (PDF 20.05 MB) GRN 890 Part 2 (PDF 22.47 MB) GRN 890 with Amendment Part 3 (PDF 2.5 MB)	FDA ceased to evaluate (PDF 189 kB)
889	Wheat germ extract	GRN 889 (PDF 8.4 MB)	FDA ceased to evaluate (PDF 236 kB)
888	Preparation containing three bacterial phages specific to Salmonella	GRN 888 (PDF 8.3 MB)	FDA ceased to evaluate (PDF 36 kB)
887	Menaquinone-7	GRN 887 with amendments (PDF 12.1 MB)	FDA has no questions (PDF 472 kB)
886	Mixture of monoacylglycerides derived from grape seed	GRN 886 (PDF 5 MB)	FDA has no questions Supplemental Response Letter (PDF 171 kB)
885	Vinyl Acetate-Vinyl Laurate Copolymers (VAVLP) as components of Chewing Gum Base	GRN 885 (PDF 2.2 MB)	FDA has no questions (PDF 451 kB)
884	Rice bran extract	GRN 884 (PDF 11.8 MB)	FDA has no questions (PDF 518 kB)
883	Ilex guayusa leaf hydroethanolic extract	GRN 883 (PDF 18.7 MB)	FDA has no questions (PDF 514 kB)
882	Rebaudioside M	GRN 882 (PDF 1.4 MB)	FDA has no questions (PDF 479 kB)
881	6'-sialyllactose sodium salt	GRN 881 (PDF 4.5 MB)	FDA has no questions (PDF 561 kB)
880	3'-sialyllactose sodium salt	GRN 880 (PDF 4.6 MB)	FDA has no questions (PDF 557 kB)
879	Fava bean protein	GRN 879 (PDF 6 MB)	FDA has no questions (PDF 502 kB)
878	Glucosylated steviol glycosides	GRN 878 (PDF 16 MB)	FDA has no questions (PDF 453 kB) Supplemental Response Letter (PDF 353 kB)
877	Bifidobacterium longum BB536	GRN 877 (PDF 5.2 MB)	FDA has no questions (PDF 74 kB)
876	Hydroxytyrosol	GRN 876 with Amendments (PDF 4.4 MB)	FDA has no questions (PDF 88 kB)
875	Bifidobacterium animalis subsp. lactis AD011	GRN 875 (PDF 3 MB)	FDA ceased to evaluate (PDF 258 kB)
874	Corn protein	GRN 874 (PDF 3 MB)	FDA ceased to evaluate (PDF 44 kB)
873	Cranberry extract	GRN 873 (PDF 4 MB)	FDA has no questions (PDF 567 kB)
872	Bifidobacterium animalis subsp. lactic UABla-12	GRN 872 (PDF 3.4 MB)	FDA has no questions (PDF 61 kB)
871	Lactobacillus acidophilus DDS-1	GRN 871 (PDF 4.0 MB)	FDA has no questions (PDF 49 kB)
870	Ilex guayusa leaf hydroethanolic extract	GRN 870 (PDF 20 MB)	FDA has no questions (PDF 550 kB)
869	Ilex guayusa leaf extract	GRN 869 (PDF 20 MB)	FDA has no questions (PDF 550 kB)
868	Coffee fruit extract	GRN 868 (PDF 3 MB)	FDA has no questions (PDF 556 kB)
867	Rebaudioside M	GRN 867 (PDF 1.8 MB)	FDA ceased to evaluate (PDF 35 kB)
866	Lipase from Penicillium camemberti	GRN 866 (PDF 653  kB)	FDA ceased to evaluate (PDF 257 kB)
865	Lactobacillus acidophilus NCFM	GRN 865 (PDF 9.33 MB)	FDA has no questions (PDF 761 kB)
864	Bacillus coagulans SNZ 1969 spore preparation	GRN 864 (PDF 8.3 MB)	FDA has no questions (PDF 560 kB)
863	B-lactoglobulin produced by Trichoderma reesei	GRN 863 (PDF 5.2 MB)	FDA has no questions (PDF 637 kB)
862	Algal oil (40% docosahexaenoic acid) from Schizochytrium sp. strain ONC-T18	GRN 862 (PDF 18.26 MB)	FDA has no questions (PDF 748 kB)
861	Pullulanase from Bacillus deramificansproduced in Bacillus subtilis	GRN 861 (PDF 1.3 MB)	FDA has no questions (PDF 605 kB)
860	Algal oil (36% docosahexaenoic acid) from Schizochytrium sp. strain DHF	GRN 860 (PDF 8.6 MB)	FDA ceased to evaluate (PDF 35 kB)
859	2'-fucosyllactose	GRN 859 (PDF 13 MB)	FDA ceased to evaluate (PDF 248 kB)
858	Glucosylated steviol glycosides	GRN 858 Part 1 (PDF 1.5 MB) GRN 858 Part 2 (PDF 9 MB) GRN 858 Part 3 (PDF 6 MB)	FDA has no questions (PDF 86 kB)
857	Phospholipase A1 produced by Aspergillus niger	GRN 857 (PDF 1.8 MB)	FDA has no questions (PDF 465 kB)
856	Bifidobacterium animalis subsp. lactis strain BB-12	GRN 856 (PDF 10.94 MB)	FDA has no questions (PDF 63 kB)
855	Bifidobacterium animalis ssp. lactis strain R0421	GRN 855 (PDF 5.0 MB)	FDA has no questions (PDF 634 kB)
854	Inulin from Agave tequilana	GRN 854 (PDF 28.5 MB)	FDA has no questions (PDF 2 MB)
853	Lysozyme produced by Trichoderma reesei	GRN 853 (PDF 1 MB)	FDA has no questions (PDF 552 kB)
852	2-fucosyllactose	GRN 852 (PDF 9.4 MB)	FDA has no questions (PDF 108 kB)
851	Pea protein	GRN 851 (PDF 1.6 MB)	FDA has no questions (PDF 601 kB)
850	Shea olein	GRN 850 (PDF 13.4 MB)	FDA has no questions (PDF 610 kB)
849	Inulin from artichoke	GRN 849 (PDF 8.56 MB)	FDA has no questions (PDF 129 kB)
848	Pea and rice protein fermented by Shitake mycelia	GRN 848 (PDF 7.6 MB)	FDA has no questions (PDF 487 kB)
846	Rebaudioside M		FDA has no questions (PDF 102 kB)
847	Lactobacillus plantarum ECGC 13110402	GRN 847 (PDF 4.7 MB)	FDA has no questions (PDF 63 kB)
846	Rebaudioside M	GRN 846 (PDF 4 MB)
845	Lactobacillus rhamnosus LGG	GRN 845 (PDF 7.6 MB)	FDA has no questions (PDF 121 kB)
844	Algal oil (55% docosahexaenoic acid) from Schizochytrium sp. strain FCC-3204	GRN 844 (PDF 3.4 MB)	FDA has no questions (PDF 105 kB)
843	Algal oil (35% docosahexaenoic acid) from Schizochytrium sp. strain FCC-1324	GRN 843 (PDF 4.9 MB)	FDA has no questions (PDF 85 kB)
842	Maltogenic alpha-amylase	GRN 842 (PDF 1.03 MB)	FDA has no questions (PDF 715 kB)
841	Saccharomyces cerevisiae expressing L-lactate dehydrogenase from Rhizopus oryzae	GRN 841 (PDF 2.7 MB)	FDA has no questions (PDF 604 kB)
840	Lactobacillus paracasei strain F19	GRN 840 (PDF 3 MB)	FDA has no questions (PDF 76 kB)
839	Purified steviol glycosides	GRN 839 (PDF 3.9 MB)	FDA has no questions (PDF 77 kB)
838	Purified steviol glycosides	GRN 838 (PDF 4.5 MB)	FDA has no questions (PDF 83 kB)
837	Hydroxytyrosol	GRN 837 (PDF 2.7 MB)	FDA ceased to evaluate (PDF 54 kB)
836	Algal oil (50-60% docosahexaenoic acid) from Schizochytrium sp. HS01	GRN 836 (PDF 2.3 MB)	FDA has no questions (PDF 74 kB)
835	Ilex guayusa leaf extract	GRN 835 (PDF 6.8 MB)	FDA ceased to evaluate (PDF 35.24 kB)
834	Preparation containing bacterial phages specific to shiga-toxin Escherichia coli	GRN 834 (PDF 11.69 MB)	FDA has no questions (PDF 91 kB)                           Supplemental Response Letter  (PDF 229 kB)
833	Lacto-N-tetraose	GRN 833 with Amendments (PDF 11MB)	FDA has no questions (PDF 701 kB)
832	Acid prolyl endopeptidase produced by Aspergillus niger	GRN 832 (PDF 2.6 MB)	FDA has no questions (PDF 284.21 kB)
831	Bacillus subtilis DE111	GRN 831 (PDF 6.4 MB)	FDA has no questions (PDF 73 kB)
830	Chicory flour	GRN 830 (PDF 1.51 MB)	FDA ceased to evaluate (PDF 53.77 kB)
829	Dried biomass of Aspergillus oryzae fermented with minerals	GRN 829 (PDF 1.3 MB)	FDA has no questions (PDF 110 kB) Additional correspondence (PDF 104 kB)
828	D-psicose	GRN 828 (PDF 1.4 MB)	FDA has no questions (PDF 550 kB)
827	Preparation containing three bacterial phages specific to Escherichia coli serotypes	GRN 827 (PDF 20 MB)	FDA has no questions (PDF 75.92 kB) Additional correspondence (PDF 447 kB)
826	Dihydroquercetin	GRN 826 (PDF 15.4 MB)	FDA ceased to evaluate (PDF 35 kB)
825	Beta-galactosidase from Kluyveromyces lactis	GRN 825 (PDF 5.0 MB)	FDA has no questions (PDF 64 kB)
824	Bacteriocin preparations specific to Salmonella	GRN 824 (PDF 6.7 MB)	FDA has no questions (PDF 71 kB)
823	Rebaudioside E	GRN 823 (PDF 6.2 MB)	FDA has no questions (PDF 757 kB)
822	Curcumin	GRN 822 (PDF 4.8 MB)	FDA has no questions (PDF 861 kB)
821	Glucosylated steviol glycosides	GRN 821 (PDF 1.6 MB)	FDA has no questions (PDF 743 kB)
820	Lactobacillus fermentum CECT5716	GRN 820 (PDF 3.62 MB)	GRN 820 (PDF 35.2 kB)
819	Fatty acid ethyl esters from Alaskan Pollock	GRN 819 (PDF 6 MB)	FDA has no questions (PDF 63 kB)
818	Isomalto-oligosaccharides	GRN 818 (PDF 3.83 MB)	FDA has no questions (PDF 126.11 kB)
817	Serine endopetidase from Melbranchea cinnamomea produced in Trichaderma reesei	GRN 817 (PDF 3.5 MB)	FDA has no questions (PDF 67.82 kB)
816	Xylooligosaccharides from sugarcane	GRN 816 (PDF 8.3 MB)	GRN 816 (PDF 68.2 kB)
815	2' -fucosyllactose and difucosyllactose	GRN 815 (PDF 3.3 MB)	FDA has no questions (PDF 657 kB) Correction Letter  (PDF 193 kB) Correction Letter  (PDF 132 kB)
814	Bifidobacterium bifidum BGN4	GRN 814 (PDF 2.5 MB)	FDA has no questions (PDF 78 kB)
813	Bifidobacterium longum BORI	GRN 813 (PDF 1.7 MB)	FDA has no questions (PDF 82 kB)
812	Rebaudioside M	GRN 812 (PDF 8 MB)	FDA has no questions (PDF 659 kB)
811	Phospholipase A1 produced by Aspergillus oryzae	GRN 811 (PDF 1.5 MB)	FDA has no questions (PDF 64 kB)
810	Lactobacillus paracasei subsp. paracasei strain F-19e	GRN 810 (PDF 1.7 MB	GRN 810 (PDF 178 kB)
809	Fractionated whey protein concentrate containing 41% alphalactalbumin	GRN 809 (PDF 6.2 MB)	FDA has no questions (PDF 315.2 kB)
808	Lipase from Aspergillus tubingensis produced in Trichoderma reesei	GRN 808 (PDF 2.4 MB)	FDA has no questions (PDF 79.73 kB)
807	Streptococcus salivarius M18	GRN 807 (PDF 2.4 MB)	FDA has no questions (PDF 66 kB)
806	Dolomite	GRN 806 (PDF 747.31 kB)	GRN 806 (PDF 275 kB)
805	Apple peel powder	GRN 805 (PDF 5.0 MB)	FDA has no questions (PDF 522 kB)
804	Pea protein	GRN 804 (PDF 5 MB)	FDA has no questions (PDF 94  kB)
803	Pea protein	GRN 803 (PDF 1.1 MB)	FDA has no questions (PDF 91 kB)
802	Endolysin	GRN 802 (PDF 5.5 MB)	GRN 802 (PDF 294 kB)
801	Chymosin enzyme from Camelus dromendarius produce in Aspergillus niger	GRN 801 (PDF 15 MB)	FDA has no questions (PDF 71 kB)
800	Gamma-oryzanol	GRN 800 Part 1 (PDF 8 MB) GRN 800 Part 2 (PDF 17 MB)	FDA has no questions (PDF 628 kB)
799	Rebaudioside M	GRN 799 (PDF 1.2 MB)	FDA has no questions (PDF 112 kB)
798	Saccharomyces cerevisiae strain yBBS002	GRN 798 (PDF 5.6 MB)	FDA has no questions (PDF 73.19 kB)
797	Fructooligosaccharides	GRN 797 (PDF 16 MB	FDA has no questions (PDF 450 kB)
796	Orange extract (85% hesperidin)	GRN 796 (PDF 11 MB)	FDA has no questions (PDF 459 kB)
795	Purified steviol glycosides	GRN 795 (PDF 10 MB)	FDA has no questions (PDF 106 kB)
794	Shiitake, pea, and rice protein fermented with Lentinula edodes	GRN 794 (PDF 11.9 MB)	FDA ceased to evaluate this notice (PDF 57 kB)
793	Cultured corn starch fermented by Corynebacterium stationis	GRN 793 (PDF 5.1 MB)	GRN 793 (PDF 171 kB)
792	Cultured corn starch fermented by Corynebacterium glutamicum	GRN 792 (PDF 7.6 MB)	GRN 792 (PDF 160 kB)
791	Urolithin A	GRN 791 (PDF 2.3 MB)	FDA has no questions (PDF 61 kB)
790	Steviol glycosides	GRN 790 (PDF 4 MB)	FDA has no questions (PDF 448 kB)
789	Erythritol	GRN 789 Part 1 (PDF 13.8 MB) GRN 789 Part 2 (PDF 13.1 MB)	FDA has no questions (PDF 80 kB)
788	Pea protein	GRN 788 with Amendments (PDF 7.2 MB)	FDA has no questions (PDF 246 kB)
787	Quinoa sprout powder	GRN 787 (PDF 12.9 MB)	FDA has no questions  (PDF 94 kB)
786	Calcium propionate	GRN 786 (PDF 2.8 MB)	FDA has no questions (PDF 70 kB)
785	Calcium chloride	GRN 785 (PDF 1.3  MB)	FDA has no questions (PDF 74 kB)
784	Siraitia grosvenorii Swingle	GRN 784 (PDF 3 MB)	FDA has no questions (PDF 664 kB)
783	Triacylglycerol lipase from Rhizopus oryzae produced in Aspergillus niger	GRN 783 Part 1 (PDF 2.7 MB) GRN 783 Part 2 (PDF 17 MB) GRN 783 Part 3 (PDF 5.9 MB) GRN 783 Part 4 (PDF 6.4 MB)	FDA has no questions (PDF 75 kB)
782	L-arabinose	GRN 782 (PDF 9.02 MB)	FDA has no questions (PDF 47 kB)
781	Alpha-tocopherol (fruit and vegetable derived)	GRN 781 (PDF 3 MB)	FDA has no questions (PDF 1 MB)
780	Rebaudioside M	GRN 780 (PDF 1 MB)	FDA has no questions (PDF 115 kB)
779	Isomalto-oligosaccharide mixture	GRN 779 (PDF 12 MB)	FDA has no questions (PDF 89 kB)
778	Hemp seed oil	GRN 778 (PDF 19 MB) GRN 778 Amendment (PDF 352 kB)	FDA has no questions (PDF 429 kB) Supplemental Response Letter (PDF 158 kB)
777	Algal oil (55% docosahexaenoic acid) from Schizochytrium sp. FCC-3204	GRN 777 (PDF 13.4 MB)	FDA has no questions (PDF 230 kB)
776	Algal oil (35% docosahexaenoic acid) from Schizochytrium sp. FCC-1324	GRN 776 (PDF 1.58 MB)	FDA has no questions (PDF 570 kB)
775	colicin proteins produced in Nicotiana benthamiana (colicin preparations)	GRN 775 (PDF 3.34 MB)	FDA has no questions (PDF 77 kB)
774	Glutaminase from Bacillus licheniformis produced in Bacillus licheniformis	GRN 774 (PDF 1.28 MB)	FDA has no questions (PDF 73 kB)
773	Dried biomass of Chlamydomonas reinhardtii	GRN 773 (PDF 4.99 MB)	FDA has no questions (PDF 149 kB)
772	Palmitoylated green tea catechins	GRN 772 (PDF 1.68 MB)	FDA has no questions (PDF 63 kB)
771	Hemp seed protein	GRN 771 Part 1 (PDF 4.4 MB) GRN 771 Part 2 Amendment (PDF 14.9 MB) GRN 771 Part 3 Amendment (PDF 352 kB)	FDA has no questions  (PDF 480 kB) Supplemental Response Letter (PDF 158 kB)
770	Potassium polyaspartate	GRN 770 (PDF 1.28 MB)	FDA has no questions (PDF 786 kB)
769	Vitamin C (fruit and vegetable derived)	GRN 769 (PDF 770 kB)	FDA has no questions (PDF 72 kB)
768	Stevia leaf extract	GRN 768 (PDF 2 MB)	FDA has no questions (PDF 100 kB)
767	Polyvinyl alcohol	GRN 767 with amendments (PDF 1.5 MB)	FDA has no questions (PDF 57 kB)
766	3’-sialyllactose sodium salt	GRN 766 (PDF 919 kB)	FDA has no questions (PDF 850 kB)
765	Hulled hemp seed	GRN 765 (PDF 19 MB) GRN 765 Amendment (PDF 352 kB)	FDA has no questions (PDF 273 kB) Supplemental Response Letter (PDF 158 kB)
764	Rebaudioside D	GRN 764 (PDF 8.46 MB)	FDA has no questions (PDF 111 kB)
763	Alpha-lactalbumin	GRN 763 with Amendments (PDF 2.5 MB)	FDA has no questions (PDF 106 kB)
762	Carnobacterium divergens M35 preparation	GRN 762 (PDF 5.4 MB)	FDA has no questions (PDF 32 kB)
761	Esterified propoxylated glycerol	GRN 761 (PDF 3.2 MB)	FDA has no questions (PDF 106 kB)
760	Lactobacillus curvatus DSM 18775	GRN 760 (PDF 3.7 MB)	FDA has no questions (PDF 77 kB)
759	Steviol glycosides consisting primarily of rebaudioside M produced in Yarrowia lipolytica	GRN 759 (PDF 3.7 MB)	FDA has no questions (PDF 106 kB)
758	Lactobacillus helveticus R0052, Bifidobacterium longum ssp. infantis R0033, and Bifidobacterium bifidum R0071	GRN 758 (PDF 5 MB) GRN 758    Amendment (PDF 630 kB)	FDA has no questions (PDF 103 kB)
757	Escherichia coli O157	GRN 757 (PDF 2 MB)	FDA has no questions (PDF 59 kB)
756	Endo-1,4-beta-glucanase from Trichoderma reesei	GRN 756 (PDF 3.5 MB)	FDA has no questions (PDF 92 kB)
755	D-psicose	GRN 755 (PDF 545 kB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 57 kB)
754	Algal oil (87% oleic acid) derived from Prototheca moriformis strain S6697	GRN 754 (PDF 15 MB)	FDA has no questions (PDF 87 kB)
753	Sodium Thiocyanate	GRN 753 (PDF 6.9 MB)	FDA has no questions (PDF 56 kB)
752	Preparation containing the bacterial monophages, BP-63 and LVR16-A, specific to Salmonella	GRN 752 (PDF 2.3 MB)	FDA has no questions (PDF 57 kB)                                                  Supplemental Response Letter (PDF 130 kB)
751	Maltogenic alpha-amylase from Bacillus stearothermophilus produced in Bacillus subtilis	GRN 751 (PDF 1.1 MB)	FDA has no questions (PDF 228 kB)
750	Beta-glucosidase	GRN 750 Part 1 (PDF 7.7 MB) GRN 750 Part 2 (PDF 16.4 MB) GRN 750 Part 3 (PDF 14 MB) GRN 750 Part 4 (PDF 20 MB)	FDA has no questions (PDF 767 kB)
749	2’-O-fucosyllactose	GRN 749 Part 1 (PDF 10.6 MB) GRN 749 Part 2 (PDF 12.2 MB)	FDA has no questions (PDF 96 kB)
748	Tomato powder	GRN 748 (PDF 3.4 MB)	FDA ceased to evaluate (PDF 45 kB)
747	Calcium lactate	GRN 747 (PDF 2.2 MB)	FDA has no questions (PDF 76 kB)
746	Maltogenic amylase from Geobacillus stearothermophilus produced in Bacillus subtilis	GRN 746 (PDF 7.1 MB)	FDA has no questions (PDF 104 kB)
745	Steviol glycosides consisting primarily of rebaudioside M	GRN 745 (PDF 1 MB)	FDA has no questions (PDF 139 kB)
744	Steviol glycosides consisting primarily of rebaudioside M	GRN 744 (PDF 1.9 MB)	FDA has no questions (PDF 131 kB)
743	β-galactosidase from Papiliotrema terrestris	GRN 743 (PDF 8.7 MB)	FDA has no questions (PDF 69 kB)
742	Duckweed (subfamily Lemnoideae) powder	GRN 742 Part 1 (PDF 9 MB) GRN 742 Part 2 (PDF 8.7 MB) GRN 742 Part 3 (PDF 11.5 MB)	FDA has no questions (PDF 64 kB)
741	Dimethyl ether	GRN 741 (PDF 403 kB)	FDA has no questions (PDF 72 kB)
740	Glycolipids from Dacryopinax spathularia	GRN 740 (PDF 3.7 MB)	FDA has no questions (PDF 94 kB)                            Supplemental Response Letter  (PDF 273 kB) Supplemental Response Letter 2 (PDF 247kB)
739	Mannanase enzyme from Talaromyces leycettanus produced in Aspergillus niger	GRN 739 (PDF 622 kB)	FDA has no questions (PDF 113 kB)
738	Thaumatin	GRN 738 (PDF 1.8 MB)	FDA has no questions (PDF 77 kB)
737	Soy leghemoglobin	GRN 737 Part 1 (PDF 10.1 MB) GRN 737 Part 2 (PDF 9.2 MB) GRN 737 Part 3 (PDF 10.4 MB) GRN 737 amendments (PDF 3.6 MB)	FDA has no questions (PDF 80 kB)
736	Lactobacillus casei subsp. paracasei Lpc-37	GRN 736 (PDF 17.6 MB)	FDA has no questions (PDF 73 kB)
735	2’-Fucosyllactose	GRN 735 Part 1 (PDF 15.5 MB) GRN 735 Part 2 (PDF 16.3 MB) GRN 735 Part 3 (PDF 10.3 MB), GRN 735 Part 4 (PDF 14.8 MB) GRN 735 Part 5 (PDF 11.8 MB) GRN 735 amendments (PDF 8.6 MB)	FDA has no questions (PDF 103 kB)                          Supplemental Response Letter (PDF 176 kB)
734	Ergothionine	GRN 734 (PDF 18.5 MB)	FDA has no questions (PDF 70 kB)
733	Purified steviol glycosides	GRN 733 Part 1 (PDF 9.8 MB) GRN 733 Part 2 (PDF 15 MB)	FDA has no questions (PDF 69 kB)
732	Docosahexaenoic acid oil produced in Schizochytrium sp.	GRN 732 (PDF 5.3 MB)	FDA has no questions (PDF 68 kB)
731	Docosahexaenoic acid oil produced in Schizochytrium sp.	GRN 731 (PDF 454 kB)	FDA has no questions (PDF 72 kB)
730	Arachidonic Acid Oil Produced in Mortierella Alpina	GRN 730 (PDF 6.8 MB) GRN 730 amendments (PDF 6.8 MB)	FDA has no questions (PDF 77 kB)
729	Galacto-oligosaccharides	GRN 729 (PDF 15 MB)	FDA has no questions (PDF 112 kB)
728	Phospholipase C from Pseudomonas sp. 62186 produced in Bacillus licheniformis	GRN 728 (PDF 730 kB)	FDA has no questions (PDF 47 kB)
727	Trehalase from Trichoderma reesei produced in Trichoderma reesei	GRN 727 (PDF 4.9 MB)	FDA has no questions (PDF 61 kB)
726	Polyphenol extract from olive	GRN 726 (PDF 7.5 MB)	FDA has no questions (PDF 66 kB)
725	Inactivated Bacillus coagulans GBI-30, 6086	GRN 725 (PDF 5.2 MB)	FDA has no questions (PDF 52 kB)
724	Preparation containing six bacterial phages specific to shiga-toxin producing Escherichia coli	GRN 724 (PDF 4.2 MB)	FDA has no questions (PDF 75 kB)
723	Benzalkonium chloride	GRN 723 (PDF 18.6 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 41 kB)
722	Lactobacillus plantarum Lp-115	GRN 722 (PDF 10.3 MB)	FDA has no questions (PDF 67 kB)
721	Galacto-oligosaccharides	GRN 721 (PDF 10 MB)	FDA has no questions (PDF 69 kB)
720	Rice bran wax	GRN 720 (PDF 23.4 MB)	FDA has no questions (PDF 73 kB)
719	Orange pomace	GRN 719 (PDF 2.1 MB)	FDA has no questions (PDF 66 kB)
718	Calcium acid pyrophosphate	GRN 718 Amendment (PDF 1 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 32 kB)
717	Short-chain fructo-oligosaccharides	GRN 717 (PDF 4.1 MB)	FDA has no questions (PDF 82 kB)                                Supplemental Response Letter (PDF 225 kB)
716	Bovine milk osteopontin	GRN 716 Part 1 with Amendments (PDF 19.9 MB) GRN 716 Part 2 (PDF 483 kB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 32 kB)
715	Rebaudioside D	GRN 715 (PDF 2.9 MB)	FDA has no questions (PDF 69 kB)
714	Subtilisin from Bacillus amyloliquefaciens produced in Bacillus subtilis	GRN 714 (PDF 10.8 MB)	FDA has no questions (PDF 53 kB)
713	Hydrolyzed pork cartilage	GRN 713 (PDF 636 kB)	FDA has no questions (PDF 65 kB)
712	Calcium acetate	GRN 712 with amendments (PDF 16.9 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 44 kB)
711	Glucan	GRN 711 (PDF 1.8 MB)	FDA has no questions (PDF 49 kB)
710	Basic methacrylate copolymer	GRN 710 (PDF 414 kB) GRN 710  Amendments (PDF 1.0 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 50 kB)
709	Pyrroloquinoline quinone disodium salt	GRN 709 (PDF 1.55 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 79 kB)
708	Triacylglycerol lipase from Rhizopus oryzae produced in Aspergillus niger		At the notifier's request, FDA ceased to evaluate this notice (PDF 52 kB)
707	Glucose oxidase from Penicillium produced in Trichoderma reesei	GRN 707 (PDF 22 MB)	FDA has no questions (PDF 51 kB)
706	Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract	GRN 706 with amendments (PDF 17.4 MB)	FDA has no questions (PDF 93 kB)
705	Distarch phosphate	GRN 705 (PDF 21.1 MB)	FDA has no questions (PDF 63 kB)
704	Corn oil (by-product of ethanol production)	GRN 704 (PDF 8.8 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 67 kB)
703	Alpha-glucosidase from Aspergillus niger produced by Trichoderma reesi	GRN 703 (PDF 10 MB)	FDA has no questions (PDF 128 kB)
702	Purified steviol glycosides	GRN 702 (PDF 11.5 MB)	FDA has no questions (PDF 65 kB)
701	Pyrroloquinoline quinone disodium salt	GRN 701 (PDF 3.7 MB)	FDA has no questions (PDF 68 kB)
700	Paracoccus carotinifaciens extract containing carotenoids	GRN 700 (PDF 17 MB)	FDA has no questions (PDF 99 kB)
699	Trehalase from Myceliophthora sepedonium produced by Aspergillus niger	GRN 699 (PDF 4.2 MB)	FDA has no questions (PDF 67 kB)
698	Paramylon isolate from Euglena gracilis	GRN 698 (PDF 4.7 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 105 kB)
697	Dried biomass of Euglena gracilis	GRN 697 (PDF 4.8 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 105 kB)
696	Dolomite	GRN 696 (PDF 897 kB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 53 kB)
695	Dimethyl ether	GRN 695 (PDF 1.8 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 46 kB)
694	Pyrroloquinoline quinone disodium salt (PQQ)	GRN 694 (PDF 6.7 MB)	FDA has no questions (PDF 72 kB)
693	D-psicose	GRN 693 (PDF 1.6 MB)	FDA has no questions (PDF 97 kB)
692	Quinoa sprout extract	GRN 692 (PDF 1.8 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 33 kB)
691	Bacillus coagulans SANK 70258 spore preparation	GRN 691 (PDF 14.3 MB)	FDA has no questions (PDF 54 kB)
690	Fruit and vegetable vitamin extract	GRN 690 with Amendments (PDF 2.6 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 117 kB)
689	Phospholipase C from Bacillus thuringiensis produced in Bacillus licheniformis	GRN 689 (PDF 870 kB)	FDA has no questions (PDF 54 kB)
688	Sodium thiocyanate	GRN 688 (PDF 2.2 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 47 kB)
687	Inulin from Agave tequilana	GRN 687 (PDF 16.5 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 54 kB)
686	Curcumin from turmeric (Curcuma longa L.)	GRN 686 (PDF 5.2 MB)	FDA has no questions (PDF 152 kB)
685	Lactobacillus plantarum strain 299v	GRN 685 (PDF 4.8 MB)	FDA has no questions (PDF 44 kB)
684	Mung bean protein isolate	GRN 684 (PDF 8.3 MB)	FDA has no questions (PDF 119 kB)
683	Canola protein isolate	GRN 683 (PDF 13.6 MB)	FDA has no questions (PDF 75 kB)
682	Lecithin from canola	GRN 682 (PDF 7.2 MB)	FDA has no questions (PDF 151 kB)
681	Dried isomaltulose syrup	GRN 681 (PDF 7.3 MB)	FDA has no questions (PDF 151 kB)
680	Alpha-L-arabinofuranosidase from Talaromyces pinophilus produced by Trichoderma reesei	GRN 680 (PDF 639 kB)	FDA has no questions (PDF 101 kB)
679	Dealcoholized fermented orange juice	GRN 679 (PDF 2.2 MB)	FDA has no questions (PDF 67 kB)
678	Alpha-cyclodextrin	GRN 678 with Amendments (PDF 9.4 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 49 kB)
677	Docosahexaenoic acid oil produced in Schizochytrium sp.	GRN 677 (PDF 12.3 MB)	FDA has no questions (PDF 101 kB)
676	Colicin	GRN 676 (PDF 1.9 MB)	FDA has no questions (PDF 90 kB)
675	Xylanase enzyme preparation produced by Trichoderma reesei carrying a xylanase gene from Talaromyces leycettanus	GRN 675 (PDF 776 kB)	FDA has no questions (PDF 76 kB)
674	Isomalto-oligosaccharides	GRN 674 (PDF 1.2 MB)	FDA has no questions (PDF 160 kB)
673	Algal fat derived from Prototheca moriformis (S7737)	GRN 673 (PDF 15.3 MB)	FDA has no questions (PDF 76 kB)
672	Preparation containing five bacterial monophages specific to Shigella spp.	GRN 672 (PDF 1.4 MB)	FDA has no questions (PDF 109 kB)
671	Galacto-oligosaccharides (GOS)	GRN 671 (PDF 4 MB)	At the notifier's request, FDA ceased to evaluate this notice (PDF 62 kB)
670	Inactivated Bacillus coagulans GBI-30, 6086	GRN 670 (PDF 325 kB)	FDA has no questions (PDF 47 kB)
669	Cow's milk-derived lactoferrin	GRN 669 Part 1 (PDF 9.4 MB) GRN 669 Part 2 (PDF 18.3 MB) GRN 669 Part 3 (PDF 9.8 MB)  GRN 669 Part 4 (PDF 14.3 MB)	FDA has no questions (PDF 168 kB)
668	Sodium formate	GRN 668 (PDF 2.6 MB)	FDA has no questions (PDF 106 kB)
667	Rebaudioside M	GRN 667 (PDF 6.5 MB)	FDA has no questions (PDF 115 kB)
666	Chondroitin sodium sulfate	GRN 666 (PDF 4.9 MB)	FDA has no questions (PDF 109 kB)
665	Lactoperoxidase system	GRN 665 (PDF 658 kB)	At the notifier's request, FDA ceased to evaluate this notice
664	Alpha-amylase from Cytophaga sp. expressed in Bacillus licheniformis	GRN 664 (PDF 1 MB)	FDA has no questions (PDF 79 kB)
663	Distarch phosphate	GRN 663 (PDF 2.6 MB)	At the notifier's request, FDA ceased to evaluate this notice
662	Glucosylated steviol glycosides (minimum purity 95%)	GRN 662 (PDF 5.9 MB)	FDA has no questions
661	Fucus vesiculosus concentrate	GRN 661 (PDF 9.7 MB)	FDA has no questions (PDF 85 kB)
660	Bacillus coagulans GBI-30, 6086	GRN 660 (PDF 3.6 MB)	FDA has no questions (PDF 81 kB)
659	Lacto-N-neotetraose	GRN 659 with Supplement (PDF 3.3 MB)	FDA has no questions                                        Supplemental Response Letter (PDF 267 kB)
658	Grapefruit extract		At the notifier's request, FDA ceased to evaluate this notice
657	Glucoamylase from Penicillum oxalicum produced in Aspergillus niger		FDA has no questions
656	Enzyme-modified steviol glycosides		FDA has no questions Supplemental Response Letter (PDF 530 kB)
655	Rice bran wax		At the notifier's request, FDA ceased to evaluate this notice
654	Cocoa butter substitute		FDA has no questions
653	Lysophospholipase from Aspergillus nishimurae expressed in Trichoderma reesei.		FDA has no questions
652	Gamma linolenic acid safflower oil	GRN 652 with Amendments (PDF 3.4 MB	FDA has no questions
651	Phospholipase A1 from Talaromyces leycettanus produced in Aspergillus niger		FDA has no questions
650	2'-O-fucosyllactose		FDA has no questions Supplemental Response Letter (PDF 530 kB) Supplemental Response Letter 2 (PDF 532 kB)
649	β-galactosidase enzyme preparation from Bacillus circulans produced in Bacillus subtilis		FDA has no questions
648	Monoglycerides		FDA has no questions Supplemental Response Letter (PDF 139 kB)
647	D-psicose		At the notifier's request, FDA ceased to evaluate this notice
646	Pecan shell fiber		FDA has no questions
645	Pullulanase from Bacillus deramificans and Bacillus acidopullulyticus expressed in Bacillus licheniformis		FDA has no questions
644	Non-fat dry goat milk and goat whey protein		FDA has no questions
643	Phosphatidylserine derived from fish		At the notifier's request, FDA ceased to evaluate this notice
642	Camelina oil		FDA has no questions
641	Pyrroloquinoline quinone disodium salt		FDA has no questions
640	Esterified propoxylated glycerol		FDA has no questions
639	Zeaxanthin from marigold		FDA has no questions
638	High purity steviol glycosides (minimum purity 97%) consisting primarily of rebaudioside A		FDA has no questions
637	Phosphatidylserine derived soy lecithin		At the notifier's request, FDA ceased to evaluate this notice
636	Phosphatidylserine derived from sunflower		At the notifier's request, FDA ceased to evaluate this notice
635	Nicotinamide riboside chloride		FDA has no questions
634	Calcium chloride		FDA has no questions
633	Whey protein		FDA has no questions
632	Rebaudioside A from Yarrowia lipolytica		FDA has no questions
631	Triacylglycerol lipase from Fusarium oxysporum produced in Trichoderma reesei		FDA has no questions
630	Preparation containing the bacterial monophages, Fo1a and S16, specific to Salmonella		At the notifier's request, FDA ceased to evaluate this notice
629	Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract		At the notifier's request, FDA ceased to evaluate this notice
628	endo-1,4-beta-xylanase from Trichoderma reesei		FDA has no questions
627	Siraitia grosvenorii Swingle (Luo Han Guo) fruit juice concentrate		FDA has no further questions
626	Steviol glycosides produced in Saccharomyces cerevisiae		FDA has no questions
625	Pyrroloquinoline quinone disodium salt		FDA has no questions
624	D-allulose 3-epimerase from Arthrobacter globiformis M30 produced in Escherichia coli		FDA has no questions
623	Fructooligosaccharides		FDA has no questions
622	Emulsified fish oil		At the notifier's request, FDA ceased to evaluate this notice
621	Emulsified algal oil		At the notifier's request, FDA ceased to evaluate this notice
620	Galacto-oligosaccharides		FDA has no questions
619	Purified steviol glycosides		FDA has no questions
618	Purified seawater		FDA has no questions
617	α-amylase from Cytophaga sp. produced in Bacillus licheniformis		At the notifier's request, FDA ceased to evaluate this notice
616	High-amylose cornstarch acetate		FDA has no questions
615	High-amylose cornstarch		FDA has no questions
614	Chromium polynicotinate		FDA has no questions
613	Apple peel powder		At the notifier's request, FDA ceased to evaluate this notice
612	Fractionated whey protein isolate containing cow’s milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2		At the notifier's request, FDA ceased to evaluate this notice
611	Fractionated whey protein isolate containing cow’s milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2		At notifier's request, FDA ceased to evaluate the notice
610	Isomaltodextrin		FDA has no questions  (PDF 166 kB)  Supplemental Response Letter  (PDF 166 kB)
609	Rice protein		Additional correspondence (PDF 81 kB) FDA has no questions
608	Pea protein concentrate		FDA has no questions
607	Glucosylated steviol glycosides (minimum purity 80%)		FDA has no questions Supplemental letter (PDF 65 kB)
606	Vinyl acetate-vinyl laurate copolymers		FDA has no questions
605	Fructo-oligosaccharides		FDA has no questions
604	Baker's Yeast (Saccharomyces cerevisiae) expressing asparaginase II		FDA has no questions
603	Preparation containing the bacterial monophages, BP-63 and BP-12, specific to Salmonella		FDA has no questions
602	N-acetyl-D-neuraminic acid		FDA has no questions
601	Bacillus coagulans SBC37-01 spore preparation		FDA has no questions
600	Hydroxytyrosol		FDA has no questions
599	Citrus fiber		FDA has no questions
598	Thermolysin enzyme preparation derived from Geobacillus stearothermophilus		FDA has no questions
597	Bacillus coagulans SNZ1969 spores preparation		FDA has no questions
596	Breadfruit flour		FDA has no questions
595	gamma-aminobutyric acid		At the notifier's request, FDA ceased to evaluate this notice
594	α-amylase from Geobacillus stearothermophilus produced in Bacillus licheniformis		FDA has no questions
593	Colicin preparations		FDA has no questions
592	β-glucanase from Bacillus subtilis		FDA has no questions
591	Streptococcus salivarius K12	GRN 591 (PDF 1.92 MB)	FDA has no questions (PDF 340 kB)
590	Pyrroloquinoline quinone		At the notifier's request, FDA ceased to evaluate this notice
589	Xylanase from Aspergillus niger		FDA has no questions
588	Zeaxanthin from Capsicum annum (paprika)		FDA has no questions; some uses may require a color additive listing
587	Acetolate decaroxylase from Bacillus brevis produced in Bacillus licheniformis		FDA has no questions
586	Taurine		FDA has no questions
585	1-methylcyclopropene		FDA has no questions
584	Cellulase from Penicillium funiculosum		FDA has no questions
583	Esterified propoxylated glycerol		FDA has no questions
571	2'-Fucosyllactose		Supplemental Response Letter  (PDF 209 kB)
565	Fucoidan from Undaria pinnatifida	GRN 565 with amendment (PDF, 5.6 MB)	Supplemental Response Letter (PDF 228 kB)
537	Short-chain fructo-oligosaccharides		Supplemental Response Letter  (PDF 386 kB)
468	Preparation containing the bacterial monophages, Fo1a and S16, specific to Salmonella		Supplemental Response Letter (PDF 98.08 kB)
452	Enzyme-modified steviol glycosides		Additional Correspondence (PDF 282 kB)
435	Preparation consisting of six bacterial monophage specific to Salmonella enterica (monophage cocktail)		Supplemental Letter (PDF 74 kB)    Supplemental Response Letter 2 (PDF 235 kB) Supplemental Response Letter 3 (PDF 220 kB)
399	Preparation of Bacillus coagulans strain GBI-30, 6086 spores	GRN 399 with Amendments (PDF 1.2 MB)
379	Tuna oil	GRN 379 with Amendments (PDF 6.5 MB)
239	Baker's yeast beta-glucan		Additional correspondence (PDF 283 kB)
236	Galacto-oligosaccharides		Supplemental response letter 2 (PDF 240 kB)
229	Methylsulfonylmethane		Additional correspondence (PDF 45 kB)
183	Phospholipase A2 enzyme preparation from Aspergillus niger expressing a gene encoding a porcine phospholipase A2		Additional correspondence (PDF 46 kB)
091	Mycoprotein		Additional correspondence (PDF 110 kB)